(PharmaNewsWire.Com, November 03, 2017 ) According to Publisher, the Global Blood Culture Test market is expected to grow from $3.01 billion in 2016 to reach $5.65 billion by 2023 with a CAGR of 9.4%. Rising new product launches & number of regulatory approvals, increasing sepsis cases, increasing incidence of bloodstream infections, growing R&D investments for development of the novel testing products and turning demand for rapid diagnostic techniques are some of the factors boosting the market growth. In addition, growing geriatric population and high predominance of infectious diseases are the other key factors promoting the market growth. However, shortage of trained laboratory technicians and huge price of automated instruments are hindering the market growth.
Based on the technologies, molecular technologies segment is expected to grow with a high CAGR during in the forecast period. Molecular technologies have a significant growth due to the factors such as rising incidence of sepsis that calls for speedy diagnostic techniques for finding the presence of mycobacteria, fungi and bacteria from blood samples. By end users, reference laboratories segment is expected to grow at the highest CAGR in the forecast period. Reference Laboratories are the developing source of blood culture tests in hospitals. They are outfitted with advanced diagnostic techniques that offer blood culture tests with a quick turnaround time. North America represents as the largest market in terms of revenue due to the local existence of multinational healthcare companies like BioMérieux SA, Roche Diagnostics, Dickinson & Company and Becton. Asia Pacific is expected to witness a brisk market growth over the forecast period. Circumstances like government actions to raise realization on the disease in public and rising awareness about early disease diagnosis are the major factors for the market growth in this region. Some of the key players in global blood culture test market include Becton, Dickinson and Company, Alere Inc., Thermo Fisher Scientific, Inc., Cepheid, Nanosphere, Inc., Bruker Corporation, Beckman Coulter, Roche Diagnostics, Iridica, T2 Biosystems, Siemens, Nanosphere Inc., BioMerieux SA and Luminex Corporation.
Regions Covered: -North America US Canada Mexico -Europe Germany UK Italy France Spain Rest of Europe -Asia Pacific Japan China India Australia New Zealand South Korea Rest of Asia Pacific -South America Argentina Brazil Chile Rest of South America -Middle East & Africa Saudi Arabia UAE Qatar South Africa Rest of Middle East & Africa
Company Profiling 12.1 Becton, Dickinson and Company 12.2 Alere Inc. 12.3 Thermo Fisher Scientific, Inc. 12.4 Cepheid 12.5 Nanosphere, Inc. 12.6 Bruker Corporation 12.7 Beckman Coulter 12.8 Roche Diagnostics 12.9 Iridica 12.10 T2 Biosystems 12.11 Siemens 12.12 Nanosphere Inc. 12.13 BioMerieux SA 12.14 Luminex Corporation
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
